Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Oncology
»
Gynecologic Neoplasms
07. August 2026
Search
medline.ch
Gynecologic Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 16666
Articles 1 - 20 / 333304
Stage-dependent performance and molecular subtype-specific relapse patterns on same-session [18F]FDG PET/contrast-enhanced CT in breast cancer.
Eur J Nucl Med Mol Imaging
Chiaravalloti A, Samarxhiu S, Portarena I, Flaminio V, D'Ascenzo N, Schillaci O, Vanni G.
PMID: 42566019 [PubMed - as supplied by publisher]
Next-generation endocrine therapy in HR+/HER2 - breast cancer: oral SERDs, ER-targeting innovations, and ctDNA-driven ESR1 mutation-guided switching.
Breast Cancer
Yao N, Xu G, Duan N, Han F, Li W, Qu J.
PMID: 42565973 [PubMed - as supplied by publisher]
Rising burden and deepening inequalities: a national study of high BMI-related uterine cancer in the United States using GBD and NHANES data.
J Gynecol Oncol
Huang J, Wu X, Xu D, Yan H, Yang Z, Jia Z.
PMID: 42565795 [PubMed - as supplied by publisher]
Relationship between bisphosphonate use and risks of recurrence and mortality among hormone receptor-positive and triple-negative breast cancer patients.
Cancer
Huang L, Cook LS, Tang MC, Doody DR, Peters U, Sun W, Huyghe JR, Malone KE, Li CI.
PMID: 42565301 [PubMed - indexed for MEDLINE]
Ultra-Hypofractionated Palliative Radiotherapy for Symptomatic Locoregionally Advanced Breast Cancer: A Prospective, Single-Arm Phase II Trial of Toxicity and Quality-of-Life Outcomes.
Breast Care (Basel)
Parambath HK, Gupta S, Thimmarayappa A, Kn YI, Ramdulari AV.
PMID: 42565057 [PubMed - as supplied by publisher]
Triple-Negative Breast Cancer: Predictive Factors for Pathological Complete Response and Prognostic Impact of Clinical, Pathological, and Radiological Parameters.
Breast Care (Basel)
Zenciroglu M, Abbasoglu P, Y, Topgul OH, Pekuz CK, Bas.
PMID: 42565028 [PubMed - as supplied by publisher]
Exposures to Drinking Water Contaminants in Community Water Systems and Risk of Ovarian Cancer in the California Teachers Study Cohort.
Environ Health Perspect
Spaur M, Hurwitz LM, Medgyesi DN, Keil AP, Beane Freeman LE, Fisher JA, Madrigal JM, Ammons S, Spielfogel ES, Bangia K, Albert PS, Sanchez TR, Lacey JV Jr, Jones RR, Ward MH.
PMID: 42564971 [PubMed - indexed for MEDLINE]
SGLT2 inhibitors and risk of distant metastasis in patients with breast cancer and type 2 diabetes: a target trial emulation with biological plausibility analysis.
EClinicalMedicine
Chen PH, Chang WC, Jhou HJ, Chen HY, Huang MH, Lee CH.
PMID: 42564795 [PubMed]
Time to diagnosis and treatment and breast cancer outcomes in young women: a systematic review protocol.
MethodsX
Jacobs W, Atwood T, Gonzalez R, Lee AW.
PMID: 42564769 [PubMed]
Understanding barriers to treatment regimen adherence in Pakistani women with polycystic ovary syndrome: a cross sectional study.
Afr Health Sci
Zulfiqar M, Akram W, Talha M, Zulnurain M, Saif E, Akhtar A.
PMID: 42564631 [PubMed - indexed for MEDLINE]
HPV-driven metabolic reprogramming promotes T cell exhaustion: targeting immunometabolic barriers with natural products.
Front Immunol
Wei L, Menghui H, Dandan Z, Xin W, Xinying C, Guangyi M, Jing M.
PMID: 42564395 [PubMed - indexed for MEDLINE]
Acupuncture modulates extracellular vesicle-miRNA-HMOX1 axis to inhibit ferroptosis in polycystic ovary syndrome: integrating machine learning, in vitro and in vivo studies.
Front Endocrinol (Lausanne)
Wu X, Li Y, Wang N, Guo S, Chen H, Chen T, Huang L, Zhou H.
PMID: 42564049 [PubMed - indexed for MEDLINE]
Essential oil-based interventions for chemotherapy-induced nausea and vomiting in women with breast cancer: a systematic review and meta-analysis.
Front Med (Lausanne)
Jin K, Yan S, Xu L.
PMID: 42564042 [PubMed]
Tolerance of chemotherapy in breast cancer patients in different age groups: A single-centre South African study.
S Afr Med J
Zwane AM, Oosthuizen G, Stopforth L, Joffe M, Martin L, .
PMID: 42563663 [PubMed - indexed for MEDLINE]
Clinicopathological features of pregnancy-associated breast cancer at Chris Hani Baragwanath Academic Hospital, South Africa.
S Afr Med J
Levenberg L, Kruger D, Cubash H, Murugan N.
PMID: 42563652 [PubMed - indexed for MEDLINE]
Hip Mass: Breast Carcinoma.
J Coll Physicians Surg Pak
Shabbir A, Osmani AH.
PMID: 42563353 [PubMed - indexed for MEDLINE]
Ultrasound-Guided, Indocyanine Green-Directed Robot-Assisted Breast Surgery for Benign Tumours.
J Coll Physicians Surg Pak
Liu N, Zhang G, Ren C, Cao J, Liao N.
PMID: 42563333 [PubMed - indexed for MEDLINE]
Tissue-stiffness-driven platelet activation emerges as a potential target for breast cancer prevention and treatment.
Cell Commun Signal
Heenkenda MK, Wang X, Zhong W, Abrahamsson A, Reustle N, Aili D, Lundberg P, Lindahl TL, Dabrosin C.
PMID: 42563161 [PubMed - indexed for MEDLINE]
Understanding barriers and facilitators to breast cancer screening: insights from South Asian women and general practitioners in Victoria, Australia.
Aust J Prim Health
Rizvi F, White V, Livingston PM, Bellingham K, McLachlan SA, Passey D, Philip J.
PMID: 42562622 [PubMed - indexed for MEDLINE]
(68)Ga-HER2 PET/CT for Predicting Pathologic Response to Neoadjuvant Therapy at Early Treatment and Preoperative Stages in HER2-Positive Breast Cancer: A Prospective Study.
J Nucl Med
Gao S, Zhang Z, Shi C, Cheng C, Ma X, Zhao X, Liu Y.
PMID: 42562610 [PubMed - as supplied by publisher]
Articles 1 - 20 / 333304
Page 1 of 16666
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy